BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31307920)

  • 1. Selecting candidates for Deep Brain Stimulation in Parkinson's disease: the role of patients' expectations.
    Geraedts VJ; Kuijf ML; van Hilten JJ; Marinus J; Oosterloo M; Contarino MF
    Parkinsonism Relat Disord; 2019 Sep; 66():207-211. PubMed ID: 31307920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of expectations in clinical outcomes after deep brain stimulation in patients with Parkinson's disease: a systematic review.
    Mameli F; Zirone E; Girlando R; Scagliotti E; Rigamonti G; Aiello EN; Poletti B; Ferrucci R; Ticozzi N; Silani V; Locatelli M; Barbieri S; Ruggiero F
    J Neurol; 2023 Nov; 270(11):5274-5287. PubMed ID: 37517038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach.
    Maier F; Lewis CJ; Horstkoetter N; Eggers C; Kalbe E; Maarouf M; Kuhn J; Zurowski M; Moro E; Woopen C; Timmermann L
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1273-81. PubMed ID: 23715910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
    Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
    Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to improve patient education on deep brain stimulation in Parkinson's disease: the CARE Monitor study.
    Dinkelbach L; Möller B; Witt K; Schnitzler A; Südmeyer M
    BMC Neurol; 2017 Feb; 17(1):36. PubMed ID: 28222691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Parkinson's Disease Patients' Characteristics by Indication for Deep Brain Stimulation: Men Are More Likely to Have DBS for Tremor.
    Dalrymple WA; Pusso A; Sperling SA; Flanigan JL; Huss DS; Harrison MB; Elias WJ; Shah BB; Barrett MJ
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31572622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation improves survival in severe Parkinson's disease.
    Ngoga D; Mitchell R; Kausar J; Hodson J; Harries A; Pall H
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):17-22. PubMed ID: 23843542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.
    Katz M; Luciano MS; Carlson K; Luo P; Marks WJ; Larson PS; Starr PA; Follett KA; Weaver FM; Stern MB; Reda DJ; Ostrem JL;
    Ann Neurol; 2015 Apr; 77(4):710-9. PubMed ID: 25627340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' Expectations and Satisfaction in Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease: 6-Year Follow-up.
    Lin HY; Hasegawa H; Mundil N; Samuel M; Ashkan K
    World Neurosurg; 2019 Jan; 121():e654-e660. PubMed ID: 30292658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation for Parkinson's disease: Australian referral guidelines.
    Silberstein P; Bittar RG; Boyle R; Cook R; Coyne T; O'Sullivan D; Pell M; Peppard R; Rodrigues J; Silburn P; Stell R; Watson P;
    J Clin Neurosci; 2009 Aug; 16(8):1001-8. PubMed ID: 19596113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease.
    Hacker ML; Currie AD; Molinari AL; Turchan M; Millan SM; Heusinkveld LE; Roach J; Konrad PE; Davis TL; Neimat JS; Phibbs FT; Hedera P; Byrne DW; Charles D
    J Parkinsons Dis; 2016; 6(1):125-31. PubMed ID: 26967937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.